+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: comparison with in vivo studies



Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: comparison with in vivo studies



Biochemical Pharmacology 78(10): 1340-1349



The ability of human embryonic stem (ES) cells to differentiate into the three germ layers has proposed its application in studying human developmental toxicity in vitro. In the current study we investigated if the prompted application could be utilized to evaluate the efficacy of a newly developed arsenic antidote, monoisoamyl dimercaptosuccinic acid (MiADMSA) against arsenic (III) and if the results obtained in vitro were in concordance with the animal model for studying developmental toxicity. On the basis of real time PCR (qRT-PCR) and cytotoxicity analysis of human embryoid bodies (EBs), we observed that arsenic (III) caused a significant down regulation of gene expression in all the three germ layers, which could be correlated with high mortality, visceral and skeletal defects in pups. Reversal of arsenic-induced dysfunctioning could be observed with concomitant treatment of MiADMSA in vitro and in vivo, indicating ES-EB model could provide toxicity information similar to in vivo model. IR spectroscopy further suggested that MiADMSA bind to arsenic to form adduct, which prevents arsenic from exerting its toxic effect in both models. To our knowledge this study provides first experimental evidence suggesting human ES cells could be utilized in studying the efficacy of drugs in a comparable manner with animal models. We conclude that the ES-EB model seems to be an effective, faster, cost effective method for predicting efficacy of a drug.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054459044

Download citation: RISBibTeXText

PMID: 19615344

DOI: 10.1016/j.bcp.2009.07.003


Related references

Monoisoamyl 2,3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach. Environmental Toxicology and Pharmacology 36(1): 231-242, 2013

Cluster characterization of mouse embryonic stem cell-derived pluripotent embryoid bodies in four distinct developmental stages. Biologicals 37(4): 235-244, 2009

Developmental expression of C-type natriuretic peptide and endothelial receptor tyrosine kinases for vasculoangiogenesis in embryonic-stem-cell-derived embryoid bodies. Hypertension 28(3): 527, 1996

Activation of hypoxic response in human embryonic stem cell-derived embryoid bodies. Experimental Biology and Medicine 233(8): 1044-1057, 2008

Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Engineering 10(11-12): 1716-1724, 2005

Activin B mediated induction of Pdx1 in human embryonic stem cell derived embryoid bodies. Biochemical and Biophysical Research Communications 362(3): 568-574, 2007

Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture. Experimental Cell Research 315(10): 1668-1682, 2009

Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extra-embryonic tissues. International Journal of Molecular Medicine 26(6): 853-859, 2010

Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnology and Bioengineering 94(5): 938-948, 2006

Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. Journal of the American Society of Nephrology 18(6): 1709-1720, 2007

Human embryonic stem cell-derived embryoid bodies exhibit multiple types of cardiac action potentials. Biophysical Journal 84(2 Part 2): 424a, 2003

BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies. Experimental Biology and Medicine 232(6): 833-843, 2007

BMPs regulate differentiation of a putative visceral endoderm layer within human embryonic stem-cell-derived embryoid bodies. Biochemistry and Cell Biology 85(1): 121-132, 2007

TGFbeta inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development. Journal of Cell Science 119(Pt 4): 759-768, 2006